Skip to content
Screener

HCA Healthcare HCA Estimated Implicit Price Concessions

Estimated Implicit Price Concessions at other companies

ARD
Ardent Health PartnersARDT
$121.53M-27.3%
CHE
ChemedCHE
$5.08M+119%
CHE
ChemedCHE
$5.23M-35.5%
CHE
ChemedCHE
$7.79M-16.5%
Renasant logo
RenasantRNST
$0.88
Renasant logo
RenasantRNST
88%

Other financials

Income statement

See full
Revenue$20.2B+8.7%
Net income$1.7B+2.8%
EPS (diluted)$7.62+11.6%

Balance sheet

See full
Cash & equivalents$1.0B+7.9%
Total debt$57.8B+12.3%
Total equity-$6.6B-51.2%
Total assets$63.3B+6.2%

Cash flow

See full
Operating cash flow$2.3B-44.5%
CapEx$1.2B+4.7%
Free cash flow$1.1B-63.6%

Valuation

See full
Market cap$88.53B+3.3%
Enterprise value$145.33B+6.7%
P/E12.9×-1.4×
P/S1.1×0.0×

Profitability

See full
Net margin8.8%+0.6pp
FCF margin7.7%-2.3pp

Returns & leverage

See full
Return on equity-124%
Debt / equity132.8×
Current ratio0.0×

Where this comes from

Reported directly by HCA Healthcare in its filing.

Tagged under the XBRL concept hca:EstimatedImplicitPriceConcessions.

The source filing: HCA Healthcare’s 10-K, filed February 10, 2026.

Filed
Feb 10, 2026, 4:27 PM EST
Fiscal year
FY2025
Accession
0001193125-26-044769

The estimates for implicit price concessions are based upon management’s assessment of historical writeoffs and expected net collections, business and economic conditions, trends in federal, state and private employer health care coverage and other collection indicators. Management relies on the results of detailed reviews of historical writeoffs and collections at facilities that represent a majority of our revenues and accounts receivable (the “hindsight analysis”) as a primary source of information in estimating the collectability of our accounts receivable. We perform the hindsight analysis quarterly, utilizing rolling twelve-months accounts receivable collection and writeoff data. We believe our quarterly updates to the estimated implicit price concession amounts at each of our hospital facilities provide reasonable estimates of our revenues and valuations of our accounts receivable. These routine, quarterly changes in estimates have not resulted in material adjustments to the valuations of our accounts receivable or period-to-period comparisons of our revenues. At December 31, 2025 and 2024, estimated implicit price concessions of $7.674 billion and $7.773 billion, respectively, had been recorded to adjust our revenues and accounts receivable to the estimated amounts we expect to collect.

Item 16. Form 10-K Summary

FAQ

What is HCA Healthcare's estimated implicit price concessions?
HCA Healthcare (HCA) reported estimated implicit price concessions of $1.92B in Q4 2025.
How has HCA Healthcare's estimated implicit price concessions changed year-over-year?
HCA Healthcare's estimated implicit price concessions decreased by 1.3% year-over-year, from $1.94B to $1.92B.
What is the long-term trend for HCA Healthcare's estimated implicit price concessions?
Over 4 years (2021 to 2025), HCA Healthcare's estimated implicit price concessions has grown at a 3.1% compound annual growth rate (CAGR), from $6.78B to $7.67B.
What does estimated implicit price concessions mean?
This represents the estimated portion of patient service revenue that the company expects it will not collect due to contractual adjustments, discounts, or inability of patients to pay. It reflects the difference between the gross charges billed and the amount the provider expects to realize as net revenue. This is a critical indicator of revenue realization risk and billing accuracy.

Ask your AI about HCA Healthcare's estimated implicit price concessions.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude